PL3197431T3 - Kompozycje do sporządzania pianki i sposoby dostarczania środka czynnego do jamy ciała - Google Patents

Kompozycje do sporządzania pianki i sposoby dostarczania środka czynnego do jamy ciała

Info

Publication number
PL3197431T3
PL3197431T3 PL15843723.6T PL15843723T PL3197431T3 PL 3197431 T3 PL3197431 T3 PL 3197431T3 PL 15843723 T PL15843723 T PL 15843723T PL 3197431 T3 PL3197431 T3 PL 3197431T3
Authority
PL
Poland
Prior art keywords
delivering
foam
methods
active agent
body cavity
Prior art date
Application number
PL15843723.6T
Other languages
English (en)
Polish (pl)
Inventor
Åke LINDAL
Original Assignee
Pharmiva Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmiva Ab filed Critical Pharmiva Ab
Publication of PL3197431T3 publication Critical patent/PL3197431T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/122—Foams; Dry foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/40—Peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0046—Ear
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/124—Aerosols; Foams characterised by the propellant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Inorganic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Biomedical Technology (AREA)
  • Endocrinology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL15843723.6T 2014-09-25 2015-09-25 Kompozycje do sporządzania pianki i sposoby dostarczania środka czynnego do jamy ciała PL3197431T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462055001P 2014-09-25 2014-09-25
PCT/SE2015/051011 WO2016048230A1 (en) 2014-09-25 2015-09-25 Foam-forming compositions and methods for delivering an active agent to a body cavity

Publications (1)

Publication Number Publication Date
PL3197431T3 true PL3197431T3 (pl) 2023-06-19

Family

ID=55581573

Family Applications (1)

Application Number Title Priority Date Filing Date
PL15843723.6T PL3197431T3 (pl) 2014-09-25 2015-09-25 Kompozycje do sporządzania pianki i sposoby dostarczania środka czynnego do jamy ciała

Country Status (16)

Country Link
US (1) US9895311B2 (enExample)
EP (2) EP3197431B1 (enExample)
JP (1) JP6659674B2 (enExample)
KR (1) KR102569954B1 (enExample)
CN (1) CN106687109B (enExample)
AU (1) AU2015322112B2 (enExample)
BR (1) BR112017006154B1 (enExample)
CA (1) CA2959717C (enExample)
DK (1) DK3197431T3 (enExample)
ES (1) ES2946510T3 (enExample)
FI (1) FI3197431T3 (enExample)
HU (1) HUE062224T2 (enExample)
PL (1) PL3197431T3 (enExample)
PT (1) PT3197431T (enExample)
RU (1) RU2710019C2 (enExample)
WO (1) WO2016048230A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9895311B2 (en) * 2014-09-25 2018-02-20 Pharmiva Ab Foam-forming compositions and methods for delivering an active to a body cavity
US20200069630A1 (en) * 2016-07-11 2020-03-05 Hennipen Life Sciences, Llc Compositions for sexually transmitted diseases
CN110785163B (zh) * 2017-05-23 2023-09-05 法尔米瓦股份公司 用于递送活性剂至体腔的泡沫形成组合物
CA3204971A1 (en) 2021-01-27 2022-08-04 Ake Lindal Composition for use in degradation of biofilm or prevention of biofilm formation
US20230000795A1 (en) * 2021-06-11 2023-01-05 Ankh Life Sciences Limited Lipid crystalline compositions with enhanced stability for topical delivery of active agent combinations

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4684479A (en) 1985-08-14 1987-08-04 Arrigo Joseph S D Surfactant mixtures, stable gas-in-liquid emulsions, and methods for the production of such emulsions from said mixtures
SE454397B (sv) * 1985-12-20 1988-05-02 Biogram Ab Stabiliserad vattenbaserad antimikrobiell veteperoxidkomposition, forfarande for framstellning derav samt anvendning derav som antimikrobiell spendoppningskomposition for mjolkproducerande djur
JPH06279228A (ja) 1993-03-30 1994-10-04 Kao Corp 発泡性組成物
US5576016A (en) * 1993-05-18 1996-11-19 Pharmos Corporation Solid fat nanoemulsions as drug delivery vehicles
JPH07197083A (ja) 1993-12-28 1995-08-01 Kao Corp 洗浄剤組成物
US5741525A (en) 1995-10-24 1998-04-21 Marshall University Research Corporation Vaginal pharmaceutical hydrogen peroxide composition
US5778886A (en) * 1996-02-27 1998-07-14 Shihata; Alfred Vaginal compositions combining a spermicidal agent and a peroxygen compound
US6156294A (en) 1999-11-28 2000-12-05 Scientific Development And Research, Inc. Composition and method for treatment of otitis media
US20020031556A1 (en) * 2000-07-21 2002-03-14 Lindahl Ake R. Stabilized hydrogen peroxide composition and method of making a stabilized hydrogen peroxide composition
US7709026B2 (en) 2001-10-29 2010-05-04 Columbia Laboratories, Inc. Low concentration of peroxide for treating or preventing vaginal infections
US20070292355A1 (en) * 2002-10-25 2007-12-20 Foamix Ltd. Anti-infection augmentation foamable compositions and kit and uses thereof
EP1592420B1 (en) 2003-01-24 2014-01-01 Stiefel Research Australia Pty Ltd Clindamycin phosphate foam
US8193244B1 (en) 2008-05-29 2012-06-05 Nevada Naturals, Inc. Antimicrobial agents
US20040197270A1 (en) * 2003-04-01 2004-10-07 Mundschenk David D. Topical formulations and delivery systems
MXPA06002163A (es) * 2003-08-25 2006-05-22 Foamix Ltd Espuma farmaceutica de penetracion.
US20050058673A1 (en) 2003-09-09 2005-03-17 3M Innovative Properties Company Antimicrobial compositions and methods
ZA200507019B (en) 2004-04-28 2008-02-27 Foamix Ltd Body cavity foams
CN101137359B (zh) 2005-03-10 2011-01-12 3M创新有限公司 治疗耳感染的方法
US20070299043A1 (en) * 2005-10-03 2007-12-27 Hunter William L Anti-scarring drug combinations and use thereof
JP2009522003A (ja) * 2005-12-29 2009-06-11 スリーエム イノベイティブ プロパティズ カンパニー 発泡性歯科用組成物及び方法
WO2008075207A2 (en) 2006-04-04 2008-06-26 Foamix Ltd. Anti-infection augmentation foamable compositions and kit and uses thereof
WO2008110872A2 (en) * 2006-06-23 2008-09-18 Foamix Ltd. Foamable compositions and kits comprising one or more of a channel agent, a cholinergic agent, a nitric oxide donor, and related agents and their uses
RU2459620C2 (ru) * 2007-03-30 2012-08-27 Лаккуре Аб Применение олигомеров молочной кислоты в лечении гинекологических расстройств
PL2020221T3 (pl) * 2007-06-19 2012-07-31 Neubourg Skin Care Gmbh & Co Kg Kremy DMS (Derma Membrane Structure) w postaci pianki
US20090239954A1 (en) * 2008-03-19 2009-09-24 Collins Gary L Phosphate buffered ophthalmic solutions displaying improved efficacy
WO2011039637A2 (en) 2009-10-02 2011-04-07 Foamix Ltd. Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
US8414868B2 (en) * 2010-02-04 2013-04-09 Ultradent Products, Inc. In situ foamable dental bleaching compositions and methods, systems and kits for bleaching teeth using such compositions
BR112015027026A8 (pt) * 2013-04-26 2018-01-30 Bioglan Ab composição para uso na redução da formação de casca e na promoção da cicatrização
US9895311B2 (en) * 2014-09-25 2018-02-20 Pharmiva Ab Foam-forming compositions and methods for delivering an active to a body cavity

Also Published As

Publication number Publication date
DK3197431T3 (da) 2023-06-06
CN106687109B (zh) 2020-10-23
US9895311B2 (en) 2018-02-20
RU2017112055A (ru) 2018-10-25
WO2016048230A1 (en) 2016-03-31
KR102569954B1 (ko) 2023-08-22
EP3197431A1 (en) 2017-08-02
AU2015322112B2 (en) 2020-10-22
FI3197431T3 (fi) 2023-05-11
PT3197431T (pt) 2023-05-10
RU2710019C2 (ru) 2019-12-24
CA2959717A1 (en) 2016-03-31
BR112017006154A2 (en) 2018-02-06
ES2946510T3 (es) 2023-07-20
HUE062224T2 (hu) 2023-10-28
EP3197431B1 (en) 2023-03-08
AU2015322112A1 (en) 2017-03-30
EP4218803A2 (en) 2023-08-02
JP6659674B2 (ja) 2020-03-04
EP4218803A3 (en) 2023-11-01
BR112017006154B1 (pt) 2024-01-23
CN106687109A (zh) 2017-05-17
EP3197431A4 (en) 2018-04-04
KR20170059000A (ko) 2017-05-29
RU2017112055A3 (enExample) 2019-03-25
CA2959717C (en) 2022-10-18
JP2017529377A (ja) 2017-10-05
US20160089333A1 (en) 2016-03-31

Similar Documents

Publication Publication Date Title
IL257318A (en) Therapeutic nanoparticles comprising a therapeutic agent and methods of making and using same
ZA201606646B (en) Therapeutic nanoparticles comprising a therapeutic agent and methods of making and using same
GB201600635D0 (en) Anchor for inplantation in body tissue
PL3273942T3 (pl) Plaster mikroigłowy do dostarczania składnika aktywnego do skóry
EP3215204A4 (en) Device and method for aerosolized delivering of substance to a natural orifice of the body
IL247795A0 (en) tco couplings and methods for shipping medical materials
SG11201610699XA (en) Manufacture and cryopreservation of fucosylated cells for therapeutic use
IL242545B (en) Compositions and methods for administering hydrophobic active substances
PL3234107T3 (pl) Limfocyty b do dostarczania in vivo środków terapeutycznych
ZA201601146B (en) Use of flecainide as an anti-connexin agent and method for potentiating the effects of a psychotropic drug
SI3104838T1 (sl) Terapevtski nanodelci, ki vsebujejo terapevtsko sredstvo, in postopki za izdelovanje in uporabo omenjenih nanodelcev
IL249058A0 (en) Improved forms of selective pi3k delta inhibitors for use in pharmaceutical formulations
EP3125944A4 (en) Methods and compositions for administering an active agent to the pleura of a patient
IL259047A (en) Nanoparticles containing a therapeutic substance, a process for their preparation and uses
HUE062224T2 (hu) Habképzõ kompozíciók és eljárások hatóanyag eljuttatására egy testüregbe
IL248621B (en) Formulations and methods for vaginal administration of antiprogestins
EP3223793A4 (en) Compositions and methods for delivering a bio-active agent or bio-active agents
ZA201907825B (en) Foam-forming compositions for delivering an active to a body cavity
HUE035918T2 (hu) Tartály aktív anyag tárolására és eljárás az elõállítására
GB201518078D0 (en) Model generation for drug determination
HK1241307A1 (en) Devices and methods for delivering a beneficial agent to a user
GB201400270D0 (en) Injectable active ingredient release compositions and methods for their production and use
GB201300437D0 (en) Injectable Active Ingredient Release Compositions and Methods for Their Production and Use
GB201408831D0 (en) Foamable formulation